RxDoctor Payments Data

Russell Hall, MD

Dermatology · Durham, NCNPI 1205923042

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $49,879 of the $65,334 with a category attached, or 76.3%. 5 manufacturers reported payments, led by Regeneron at 50.9% of the total. 2025 is the largest year on record at $29,777, 5.2 times the $5,680 reported in 2019. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$65,334in general payments, 2019–2025

Across 53 payments — averaging $1232.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$33K
  • Sanofi$18K
  • Argenx US, Inc.$13K
  • Almirall LLC$650
  • F. Hoffmann-la Roche AG$505
$308,279in research payments, 2019–2025

Across 48 payments — averaging $6422.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Argenx US, Inc.$277K
  • Principia Biopharma Inc.$16K
  • Astrazeneca UK Limited$15K
  • Sanofi US Services Inc.$767

What the payments were for

  • Consulting fees$49,87976%
  • Speaking & faculty fees$8,81713%
  • Travel & lodging$5,4138%
  • Food & beverage$1,2242%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron32$33,254
Sanofi8$17,643
Argenx US, Inc.11$13,282
Almirall LLC1$650
F. Hoffmann-la Roche AG1$505

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$65,334 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$6,718
Medicare patients
51
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →